EP2480221A2 - Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process - Google Patents
Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said processInfo
- Publication number
- EP2480221A2 EP2480221A2 EP10819449A EP10819449A EP2480221A2 EP 2480221 A2 EP2480221 A2 EP 2480221A2 EP 10819449 A EP10819449 A EP 10819449A EP 10819449 A EP10819449 A EP 10819449A EP 2480221 A2 EP2480221 A2 EP 2480221A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- powder
- energy
- gum
- chewing gum
- nicotine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015218 chewing gum Nutrition 0.000 title claims abstract description 145
- 229940112822 chewing gum Drugs 0.000 title claims abstract description 140
- 238000000034 method Methods 0.000 title claims abstract description 64
- 230000008569 process Effects 0.000 title claims abstract description 53
- 238000004519 manufacturing process Methods 0.000 title description 10
- 239000000843 powder Substances 0.000 claims abstract description 224
- 238000007493 shaping process Methods 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 110
- 229920000591 gum Polymers 0.000 claims description 79
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 73
- 229960002715 nicotine Drugs 0.000 claims description 71
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 70
- 239000002585 base Substances 0.000 claims description 56
- 239000000796 flavoring agent Substances 0.000 claims description 26
- 235000019634 flavors Nutrition 0.000 claims description 26
- 229920005989 resin Polymers 0.000 claims description 23
- 239000011347 resin Substances 0.000 claims description 23
- 239000006172 buffering agent Substances 0.000 claims description 18
- -1 flakes Substances 0.000 claims description 17
- 239000004615 ingredient Substances 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 229920001429 chelating resin Polymers 0.000 claims description 14
- 229920000858 Cyclodextrin Polymers 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 13
- 238000007906 compression Methods 0.000 claims description 13
- 230000006835 compression Effects 0.000 claims description 13
- 235000003599 food sweetener Nutrition 0.000 claims description 13
- 239000003765 sweetening agent Substances 0.000 claims description 13
- 229920002125 Sokalan® Polymers 0.000 claims description 12
- 239000003086 colorant Substances 0.000 claims description 11
- 238000001311 chemical methods and process Methods 0.000 claims description 10
- 238000005469 granulation Methods 0.000 claims description 10
- 230000003179 granulation Effects 0.000 claims description 10
- 239000000314 lubricant Substances 0.000 claims description 10
- 239000003826 tablet Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 8
- 238000005056 compaction Methods 0.000 claims description 8
- 210000003296 saliva Anatomy 0.000 claims description 8
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 7
- 239000011324 bead Substances 0.000 claims description 7
- 238000000280 densification Methods 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000009495 sugar coating Methods 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 5
- 239000012458 free base Substances 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 5
- KNIUHBNRWZGIQQ-UHFFFAOYSA-N 7-diethoxyphosphinothioyloxy-4-methylchromen-2-one Chemical compound CC1=CC(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 KNIUHBNRWZGIQQ-UHFFFAOYSA-N 0.000 claims description 4
- 229920000161 Locust bean gum Polymers 0.000 claims description 4
- 229920005654 Sephadex Polymers 0.000 claims description 4
- 239000012507 Sephadex™ Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000679 carrageenan Substances 0.000 claims description 4
- 229920001525 carrageenan Polymers 0.000 claims description 4
- 229940113118 carrageenan Drugs 0.000 claims description 4
- 229920001971 elastomer Polymers 0.000 claims description 4
- 239000000806 elastomer Substances 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 210000000887 face Anatomy 0.000 claims description 4
- 238000009501 film coating Methods 0.000 claims description 4
- 239000012847 fine chemical Substances 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 235000015110 jellies Nutrition 0.000 claims description 4
- 239000008274 jelly Substances 0.000 claims description 4
- 235000010420 locust bean gum Nutrition 0.000 claims description 4
- 239000000711 locust bean gum Substances 0.000 claims description 4
- 239000007937 lozenge Substances 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 210000000214 mouth Anatomy 0.000 claims description 4
- 235000010603 pastilles Nutrition 0.000 claims description 4
- 229920001277 pectin Polymers 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 229920001467 poly(styrenesulfonates) Polymers 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000005245 sintering Methods 0.000 claims description 4
- 238000009491 slugging Methods 0.000 claims description 4
- 230000000391 smoking effect Effects 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 230000009466 transformation Effects 0.000 claims description 4
- 244000061176 Nicotiana tabacum Species 0.000 claims description 3
- 208000025569 Tobacco Use disease Diseases 0.000 claims description 3
- 239000007888 film coating Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000001993 wax Substances 0.000 claims description 3
- DPEYHNFHDIXMNV-UHFFFAOYSA-N (9-amino-3-bicyclo[3.3.1]nonanyl)-(4-benzyl-5-methyl-1,4-diazepan-1-yl)methanone dihydrochloride Chemical compound Cl.Cl.CC1CCN(CCN1Cc1ccccc1)C(=O)C1CC2CCCC(C1)C2N DPEYHNFHDIXMNV-UHFFFAOYSA-N 0.000 claims description 2
- YZUPZGFPHUVJKC-UHFFFAOYSA-N 1-bromo-2-methoxyethane Chemical compound COCCBr YZUPZGFPHUVJKC-UHFFFAOYSA-N 0.000 claims description 2
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-sulfosalicylic acid Chemical compound OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 240000000972 Agathis dammara Species 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 241000416162 Astragalus gummifer Species 0.000 claims description 2
- 229920001412 Chicle Polymers 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- 229920002871 Dammar gum Polymers 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920000569 Gum karaya Polymers 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-M L-tartrate(1-) Chemical compound OC(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-M 0.000 claims description 2
- 240000001794 Manilkara zapota Species 0.000 claims description 2
- 235000011339 Manilkara zapota Nutrition 0.000 claims description 2
- 229920000175 Pistacia lentiscus Polymers 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 241000934878 Sterculia Species 0.000 claims description 2
- 229920001615 Tragacanth Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 238000005273 aeration Methods 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229920001448 anionic polyelectrolyte Polymers 0.000 claims description 2
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 2
- 229920001222 biopolymer Polymers 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 230000001055 chewing effect Effects 0.000 claims description 2
- 239000003623 enhancer Substances 0.000 claims description 2
- 238000001125 extrusion Methods 0.000 claims description 2
- 235000010492 gellan gum Nutrition 0.000 claims description 2
- 239000000216 gellan gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 235000019314 gum ghatti Nutrition 0.000 claims description 2
- 235000015220 hamburgers Nutrition 0.000 claims description 2
- 235000010494 karaya gum Nutrition 0.000 claims description 2
- 239000000231 karaya gum Substances 0.000 claims description 2
- 229940039371 karaya gum Drugs 0.000 claims description 2
- 239000004005 microsphere Substances 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 239000000025 natural resin Substances 0.000 claims description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229960000292 pectin Drugs 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 235000010487 tragacanth Nutrition 0.000 claims description 2
- 239000000196 tragacanth Substances 0.000 claims description 2
- 229940116362 tragacanth Drugs 0.000 claims description 2
- 238000007666 vacuum forming Methods 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000010457 zeolite Substances 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 229940001468 citrate Drugs 0.000 claims 1
- 229940049920 malate Drugs 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 28
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 28
- 239000004376 Sucralose Substances 0.000 description 23
- 235000019408 sucralose Nutrition 0.000 description 23
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 23
- 229920003023 plastic Polymers 0.000 description 22
- 239000004033 plastic Substances 0.000 description 22
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 20
- 239000000905 isomalt Substances 0.000 description 20
- 235000010439 isomalt Nutrition 0.000 description 20
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 20
- 239000000463 material Substances 0.000 description 18
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 17
- 239000000619 acesulfame-K Substances 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 17
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 17
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 16
- 229920001100 Polydextrose Polymers 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 235000019359 magnesium stearate Nutrition 0.000 description 14
- 235000013856 polydextrose Nutrition 0.000 description 14
- 239000001259 polydextrose Substances 0.000 description 14
- 229940035035 polydextrose Drugs 0.000 description 14
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 10
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 229920005862 polyol Polymers 0.000 description 10
- 150000003077 polyols Chemical class 0.000 description 10
- 235000010356 sorbitol Nutrition 0.000 description 10
- 239000000600 sorbitol Substances 0.000 description 10
- 238000002156 mixing Methods 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- 229940001593 sodium carbonate Drugs 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 241000208125 Nicotiana Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000007907 direct compression Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 239000000395 magnesium oxide Substances 0.000 description 5
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 5
- 235000012245 magnesium oxide Nutrition 0.000 description 5
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 5
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 4
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 4
- 230000003139 buffering effect Effects 0.000 description 4
- 235000017803 cinnamon Nutrition 0.000 description 4
- 230000001427 coherent effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229940015769 nicotine chewing gum Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 235000010358 acesulfame potassium Nutrition 0.000 description 3
- 229960004998 acesulfame potassium Drugs 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000007891 compressed tablet Substances 0.000 description 3
- 239000002826 coolant Substances 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 229940099112 cornstarch Drugs 0.000 description 3
- 229940097362 cyclodextrins Drugs 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 229960000281 trometamol Drugs 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229960005164 acesulfame Drugs 0.000 description 2
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- 239000008122 artificial sweetener Substances 0.000 description 2
- 235000021311 artificial sweeteners Nutrition 0.000 description 2
- 229960004853 betadex Drugs 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000018984 mastication Effects 0.000 description 2
- 238000010077 mastication Methods 0.000 description 2
- 239000008368 mint flavor Substances 0.000 description 2
- LDMPZNTVIGIREC-ZGPNLCEMSA-N nicotine bitartrate Chemical compound O.O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 LDMPZNTVIGIREC-ZGPNLCEMSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000007967 peppermint flavor Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000009498 subcoating Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- 229930182840 (S)-nicotine Natural products 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 241000723382 Corylus Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 101710084933 Miraculin Proteins 0.000 description 1
- 108050004114 Monellin Proteins 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940095643 calcium hydroxide Drugs 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229940023913 cation exchange resins Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 235000020057 cognac Nutrition 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000013531 gin Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000004247 glycine and its sodium salt Substances 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000012811 non-conductive material Substances 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000013533 rum Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229940071207 sesquicarbonate Drugs 0.000 description 1
- 235000020046 sherry Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 229940029258 sodium glycinate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- WUWHFEHKUQVYLF-UHFFFAOYSA-M sodium;2-aminoacetate Chemical compound [Na+].NCC([O-])=O WUWHFEHKUQVYLF-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940097346 sulfobutylether-beta-cyclodextrin Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 235000015870 tripotassium citrate Nutrition 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/02—Apparatus specially adapted for manufacture or treatment of chewing gum
- A23G4/04—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Definitions
- the RF-technology offers a possibility of manufacturing nicotine-comprising chewing gums that may result in the following advantages over other gum manufacturing methods, such as (i) improved mouth- feel with RF-treated gums being less crumbly than directly compressed gums; (ii) formulations with higher gum base content than is currently possible with direct compression of gum base material; (iii) incorporating encapsulated ingredients, such as flavors, buffers and other additives that would be broken if manufactured using direct compression or mixing, rolling and scoring, (iv) including flakes of polyols and/or sugar in the formulation to provide a crispy/crunchy mouth-feel, and/or (v) Other gum shapes possible in comparison with manufacturing using rolling-and-scoring.
- RF energy is one type of electromagnetic energy (EM energy). As will be seen below also other types of EM energy may be useful in the present invention.
- the present invention features a process for making a nicotine- comprising chewing gum by (i) dispensing a powder portion from a gum-base- comprising powder , (ii) optionally shaping said powder portion into a powder aggregate, and (iii) applying sufficient electromagnetic energy (EM energy) to said powder portion or said powder aggregate to transform said powder portion or said powder aggregate into said chewing gum, whereby said EM energy is RadioFrequency (RF) energy, Micro Wave (MW) energy, InfraRed (IR) energy, Ultraviolet (UV) energy or combinations thereof, preferably Radio Frequency (RF) energy, the combination of RF energy and IR energy, the combination of RF energy and MW energy, and the combination of RF energy, IR energy and MW energy.
- RF RadioFrequency
- MW Micro Wave
- IR InfraRed
- UV Ultraviolet
- the EM energy has a frequency such that it is non-ionizing, meaning below about 1000 THz.
- the present invention also features a nicotine-comprising chewing gum made by such process.
- said nicotine-comprising chewing gum further comprises one or more deposits.
- said nicotine-comprising chewing gum may be coated.
- FIG. 1 A is a side view of an embodiment of the invention showing gum-base- comprising powder 30 dispensed into a die 20.
- FIG. IB is a side view of an embodiment of the invention showing a powder portion 40 being densified between an upper punch 10 and a lower punch 15 thereby being shaped into a powder aggregate.
- FIG. 1C is a side view of an embodiment of the invention showing chewing gum 45 pushed by the upper punch 10 from the die 20 into blister 50.
- FIG. ID is a side view of an embodiment of the invention showing chewing gum 45 pushed from the die 20 by the lower punch 15.
- the gum base may be of any conventional gum base known in the art.
- Natural gum bases include, but are not limited to, chicle, jelutong-, lechi de caspi-, soh-, siak-, katiau-, sorwa-, balata-, pendare-, malaya-, and peach gums; natural cautchouc; and natural resins such as dammar and mastix.
- Synthetic gum bases may comprise elastomers (polymers, masticating substances), plasticizer (resin, elastomers, solvent, hydrophobic resin), filler (texturizer, water-insoluble adjuvant), softener (fat), emulsifier, wax, antioxidant, and anti-tacking agents (vinyl polymer hydrophilic resin).
- elastomers polymers, masticating substances
- plasticizer resin, hydrophobic resin
- filler texturizer, water-insoluble adjuvant
- softener fat
- emulsifier wax
- antioxidant antioxidant
- anti-tacking agents vinyl polymer hydrophilic resin
- gum bases including agar, alginate, Arabic gum, carob gum, carrageenan, ghatti gum, guar gum, karaya gum, pectin, tragacanth, locust bean gum, gellan gum and xanthan gum.
- DC-gum bases are co-processed materials, where conventional gum base is mixed with other excipients, such as polyols and anti-caking agents, and the powder mix is then processed to form composite particles comprising the ingredients of said mix.
- Several grades of DC-gum bases are commercially available, under trade names such as HiG PWD-03 (Cafosa Corporation, Spain).
- HiG PWD-03 The upper limit of conventional gum base content in DC-gum base is about 35% (w/w). Higher contents of conventional gum base in the DC-gum base is not feasible due to excessive sticking of DC-gum base to the dies, punches and other surfaces of a tablet press.
- the weight percentage of gum base in the gum-base comprising powder is from about 10% to about 80%, preferably from about 20% to about 80 %, more preferably from about 30% to about 80%, and even more preferably from about 40% to about 70%.
- the gum-base comprising powder has an average particle size of less than 2000 microns, preferably less than 1000 microns, and even more preferably less than 500 microns and most preferably less than 300 microns.
- the gum base-comprising powder or powder blend and/or the one or more deposits comprise(s) nicotine in any form.
- the nicotine may be present in its free base form.
- nicotine salts are known and may be used. Examples include, but are not limited to, formic (2: 1), acetic (3: 1), propionic (3: 1), butyric (3: 1), 2-methylbutyric (3: 1), 3-methylbutynic (3: 1), valeric (3: 1), lauric (3: 1), palmitic (3: 1), tartaric (1 : 1) and (2: 1), citric (2: 1), malic (2: 1), oxalic (2: 1), benzoic (1 : 1), gentisic (1 : 1), gallic (1 : 1), phenylacetic (3: 1), salicylic (1 : 1), phthalic (1 : 1), picric (2: 1), sulfosalicylic (1 : 1), tannic (1 :5), pectic (1 :3), alginic (1 :2), hydrochloric (2: 1), chloroplatinic (1 : 1), silcotungstic (1 : 1), pyruvic (2: 1), glutamic (1
- the nicotine in any form is bound to a resin (e.g., a polyacrylate resin), zeolite, or cellulose or starch microsphere.
- a resin e.g., a polyacrylate resin
- zeolite e.g., a polyacrylate resin
- cation exchange resins include, but are not limited to, Amberlite IRC 50 (Rohm & Haas), Amberlite IRP 64 (Rohm & Haas), Amberlite IRP 64M (Rohm & Haas), BIO-REX 70 (BIO-RAD Lab.), Amberlite IR 118 (Rohm & Haas), Amberlite IRP 69 (Rohm & Haas), Amberlite IRP 69M (Rohm & Haas), BIO-REX 40 (BIO-RAD Lab.), Amberlite IR 120 (Rohm & Haas), Dowex 50 (Dow Chemical), Dowex 50W (Dow Chemical), Duolite C 25
- the nicotine in any form is in the form of an inclusion complex with a cyclodextrin, which may include cyclodextrin complexation, such as complexation of the active pharmaceutically compound with cyclodextrin where preferably the cyclodextrin used is chosen among ⁇ -, ⁇ - and ⁇ -cyclodextrin, the hydroxypropyl derivatives of ⁇ -, ⁇ - and ⁇ -cyclodextrin, sulfoalkylether cyclodextrins such as sulfobutylether ⁇ -cyclodextrin, alkylated cyclodextrins such as the randomly methylated ⁇ -cyclodextrin, and various branched cyclodextrins such as glucosyl- and maltosyl ⁇ -cyclodextrin.
- cyclodextrin complexation such as complexation of the active pharmaceutically compound with cyclodextrin
- the nicotine is dosed in the chewing gum to provide the person with a dose to achieve an effect, e.g. to provide a sense of smoking satisfaction without smoking and/or to reduce of the urge to smoke or use tobacco.
- This amount may, of course, vary from person to person.
- the chewing gum comprises nicotine in an amount of from about 0.05 mg to about 12 mg calculated as the free base form of nicotine per chewing gum, such as from about 0.2 mg to about 8 mg, more preferably from about 0.5mg to about 6 mg, and even more preferably from about 1 mg to about 5 mg.
- This may in different embodiments include 0.05, 0.5, 1 , 1.5, 2, 3, 4, 4.5, 5, 6, 7, 8, 9, 10 or 12 mg calculated as the free base form of nicotine per chewing gum.
- the nicotine may be present in different parts of the chewing gum. If one or more deposits are present, said deposits may comprise nicotine in any form.
- the nicotine may be present in the chewing gum in more than one form, e.g. as resinate as well as hydrogen tartrate salt.
- the nicotine may be present in different forms in different parts of the chewing gum.
- the chewing gum further comprises one or more buffering agents.
- the chewing gum is buffered such that upon administration of the gum, the pH of the saliva is transiently increased from about 0.2 to about 4 pH units, preferably from abot 0.4 to about 2 pH units.
- the buffering is designed so as to achieve a transient buffering of the saliva of a subject during mastication of the chewing gum. As the change is transient, the pH will return to its normal value after a certain period of time.
- buffering agents include, but are not limited to, carbonates including carbonate, bicarbonate or sesquicarbonate, glycinate, phosphate, glycerophosphate or citrate of an alkali metal, such as potassium or sodium, or ammonium such as trisodium or tripotassium citrate, trisodium phosphate, disodium hydrogen phosphate, tripotassium phosphate, dipotassium hydrogen phosphate, calcium hydroxide, sodium glycinate and trometamol (TRIS).
- Alkali metal carbonates, glycinates and phosphates are preferred buffering agents.
- the one or more buffering agents may to some extent be microencapsulated or otherwise coated as granules with polymers and/or lipids being less soluble in saliva than is the one or more buffering agents. Such microencapsulation controls the dissolution rate whereby is extended the time frame of the buffering effect.
- a second or auxiliary buffering agent to the first buffering agent, such as e.g., sodium or potassium bicarbonate buffers.
- the second or auxiliary buffering agent may be selected from the group consisting of alkali metal bicarbonates that are preferred for this purpose.
- further embodiments of the invention may comprise a mixture of an alkali metal carbonate or phosphate and alkali metal bicarbonate.
- the buffering agent may be present in different parts of the chewing gum. If one or more deposits are present, said deposits may comprise buffering agents.
- the buffering agent may be present in the chewing gum in more than one form, e.g. as sodium carbonate as well as trometamol.
- the amount of the buffering agent or agents in the chewing gum composition is preferably sufficient in the specific embodiments to raise the pH of the saliva to above 7, as specified above, to transiently maintain the pH of the saliva in the oral cavity above 7, e.g., pH 7-10.
- the nicotine may be administered in different forms.
- the amount of buffer required to achieve said increase in pH with the different nicotine forms is readily calculated by the skilled man in the art. The extent and duration of the increase in pH is dependent on type and amount of the buffering agent(s) used as well as where the buffer is distributed in the chewing gum.
- a nicotine-comprising chewing gum is manufactured by (i) dispensing a powder portion from a gum-base-comprising powder , (ii) optionally shaping said powder portion into a powder aggregate, and (iii) applying sufficient electromagnetic energy (EM energy) to said powder portion or said powder aggregate to transform said powder portion or said powder aggregate into said chewing gum, whereby said EM energy is Radio Frequency (RF) energy, Micro Wave (MW) energy , InfraRed (IR) energy or Ultraviolet (UV) energy or combinations thereof, preferably Radio Frequency (RF) energy, the combination of RF energy and IR energy, the combination of RF energy and MW energy, and the combination of RF energy, IR energy and MW energy.
- RF Radio Frequency
- excipients include, but are not limited to, softeners, fillers, thickening agents, emulsifiers, glidants, lubricants, sweeteners, flavors and aromatics, enhancers, coloring agents and
- fillers include, but are not limited to, polydextrose, hydrogenated starch hydrosylate and corn starch.
- lubricants include, but are not limited to, long chain fatty acids and their salts, such as magnesium stearate and stearic acid, talc, glycerides waxes, and mixtures thereof.
- glidants include, but are not limited to, colloidal silicon dioxide.
- sweeteners include, but are not limited to, synthetic or natural sugars; artificial sweeteners such as saccharin, sodium saccharin, aspartame, acesulfame, thaumatin, glycyrrhizin, sucralose, dihydrochalcone, alitame, miraculin, monellin, and stevside; sugar alcohols such as sorbitol, mannitol, glycerol, lactitol, malitol, and xylitol; sugars extracted from sugar cane and sugar beet (sucrose), dextrose (also called glucose), hydrogenated starch hydrosylate, starch, maltodextrin, fructose (also called laevulose), and lactose (also called milk sugar); isomalt, salts thereof, and mixtures thereof.
- artificial sweeteners such as saccharin, sodium saccharin, aspartame, acesulfame, thaumatin
- flavors and aromatics include, but are not limited to, essential oils including distillations, solvent extractions, or cold expressions of chopped flowers, leaves, peel or pulped whole fruit comprising mixtures of alcohols, esters, aldehydes and lactones; essences including either diluted solutions of essential oils, or mixtures of synthetic chemicals blended to match the natural flavor of the fruit (e.g., strawberry, raspberry and black currant); artificial and natural flavors of brews and liquors, e.g., cognac, whisky, rum, gin, sherry, port, and wine; tobacco, coffee, tea, cocoa, and mint; fruit juices including expelled juice from washed, scrubbed fruits such as lemon, orange, and lime; spear mint, pepper mint, wintergreen, cinnamon, cacoe/cocoa, vanilla, liquorice, menthol, eucalyptus, aniseeds nuts (e.g., peanuts, coconuts, hazelnuts, chestnuts, walnuts, colanuts), almonds, raisins; and
- coloring agents include, but are not limited to, dyes being approved as a food additive.
- one or more of the excipients ingredients is present in encapsulated form and/or as flakes or part of flakes and/or fracture sensitive formats.
- the gum base and excipients, and optionally the nicotine in any form, such as discussed above, are mixed by any suitable method known in the art to form a powder or a powder blend.
- the powder or powder blend is then dispensed into separate powder portions, each powder portion comprising an amount of powder or powder blend suitable for a chewing gum.
- the shape of the final chewing gum can be set by dispensing said powder portion into a pre-shaped mold, die, other cavity or other shape- forming means.
- the powder portion may optionally be densified by tamping, compression, compaction, de-aeration, vacuum- forming, slugging, granulation, vibration or other suitable method.
- the shaped, optionally densified powder aggregate may then be transformed into chewing gum by the application of
- EM energy electromagnetic energy
- EM energy electromagnetic energy
- EM energy is Radio Frequency (RF) energy, Micro Wave (MW) energy , InfraRed (IR) energy or Ultraviolet (UV) energy or combinations thereof, preferably Radio Frequency (RF) energy, the combination of RF energy and IR energy, the combination of RF energy and MW energy, and the combination of RF energy, IR energy and MW energy.
- RF Radio Frequency
- one or more deposits may be added to the powder portion, the powder aggregate or the chewing gum.
- the type of EM energy, or optionally the mixture of EM energy types, which is most useful in the specific situation depends on the properties of the components making up the powder, the powder blend and/or the optional deposits. Such properties include e g the frequency/ies at which the electromagnetic interaction is optimal.
- the energy required per weight unit of the powder or the powder blend for transforming said powder or powder blend into a chewing gum is also depending on the electromagnetic interaction properties of the components making up the powder, powder blend and optional deposits.
- the skilled person is able to calculate or assess the energy amount required for obtaining the chewing gum.
- choice of frequency for the EM energy is very important. For example may a certain frequency result in a very short time of manufacture, while at the same time quality of the resulting chewing gum will be unsatisfactory.
- the excipients When the excipients have very different electromagnetic interaction properties it may be useful to use combinations of different EM energies.
- the respective frequencies and powers for said EM energies may be optimized through testing according to principles known to the person skilled in the art.
- optimizing application of the RF energy requires the taking into account of different parameters, such as choice electromagnetic frequency in relation to e g degree of electromagnetic interaction, industrial standards and effects on other objects than the product being treated, power of the RF apparatus, time for applying the RF energy, absorbed energy per weight unit of the product being treated, coefficient of utilization and batch size.
- the captioned reasoning applies mutatis mutandis to other types of EM energy.
- EM energy may be combined with thermal energy and/or mechanical energy.
- the powder portion is shaped into a powder aggregate using e.g. a punch and die apparatus.
- the powder or powder blend is fed into a die of an apparatus that applies pressure to shape a powder aggregate.
- Any suitable apparatus may be used, including, but not limited to, a conventional unitary or rotary tablet press such as those commercially available from Fette America Inc., Rockaway, N.J. or Manesty Machines LTD, Liverpool, UK.
- the powder aggregate is treated with RF energy within the tablet press. In another embodiment, said powder aggregate is treated with RF energy after having been removed from the tablet press.
- a powder portion 30 is dispensed from a gum-base-comprising powder into a die 20, where the powder portion 30 is either gravity fed or mechanically fed from a feeder (not shown) of a rotary tablet press, and the die rotates as part of a die table from the filling position (FIG 1 A) to a densification position (FIG IB).
- the powder portion 30 is densified between an upper punch 10 and a lower punch 15 to shape a powder aggregate 40.
- the resulting powder aggregate 40 is then exposed to RF energy to form the chewing gum 45.
- the chewing gum 45 is pushed by the upper punch 10 from the die 20 into a blister 50 used to package the chewing gum 45.
- the chewing gum 45 is pushed from the die 20 by the lower punch 15 and guided to an ejection chute by a stationary "take-off bar (not shown).
- the densification step occurs in an indexed manner, where one set of powder portions are densified simultaneously, before rotating to another indexing station.
- the densification step occurs at a single indexing station and the application of RF energy occurs at a separate indexing station.
- a third indexing station is present wherein the ejection of the chewing gum or multiple chewing gums occurs, wherein the lower punch is raised up through and up to the surface of the die.
- the densification step is performed through the addition of air pressure or hydraulic cylinder to the top of the upper punches.
- multiple chewing gums are ejected simultaneously and separated from the surface of the indexing station and removed via a take-off bar.
- the powder portion may be shaped by methods and apparatus described in United States Patent Application Publication No. 20040156902.
- the powder aggregate is shaped using a rotary compression module including a fill zone, insertion zone, compression zone, ejection zone, and purge zone in a single apparatus having a double row die construction.
- the dies of the compression module may then be filled using the assistance of a vacuum, with filters located in or near each die.
- the purge zone of the compression module includes an optional powder blend recovery system to recover excess powder blend from the filters and return the powder blend to the dies.
- the die table is constructed of non-conductive material.
- the transformation of the powder portion and/or the powder aggregate into a chewing gum may be obtained by sintering and/or fusing and/or melting and/or mechanical interlocking.
- the gum-base-comprising powder portion may be dispensed on top of a deposit such as, but not limited to, a directly compressed tablet, a hard-boiled lozenge or a jelly gum, whereby such a deposit may interact very weakly, or not at all, with RF energy.
- a deposit such as, but not limited to, a directly compressed tablet, a hard-boiled lozenge or a jelly gum, whereby such a deposit may interact very weakly, or not at all, with RF energy.
- the chewing gum may have one of a variety of different shapes. For example, it may be shaped as a parallelepiped, a three-dimensional representation of a spinnaker, a crescent, a hamburger, a disc, a heart, a polygon, a hexaflexagon, a circular object, an oval object, an oblong object, a polyhedron, such as a cube, a pyramid, a prism, a triangle, or the like; a space figure with some non-flat faces, such as a cone, a truncated cone, a cylinder, a sphere, a capsule-shaped object, a torus, or the like, whereby the chewing gum optionally has one or more major faces
- a vibratory step is utilized (e.g., added after dispensing of the powder portion but prior to the RF treatment step, in order to shape and densify the powder portion into a powder aggregate).
- a vibration with the frequency from about 1 Hz to about 50 KHz is added with amplitude from 1 micron to 5 mm peak-to-peak is utilized to shape and densify the powder portion into a powder aggregate.
- a lubricant is added to the cavity prior to the dispensing of the powder portion.
- This lubricant may be a liquid or solid.
- Suitable lubricants include, but are not limited to solid lubricants such as magnesium stearate, starch, calcium stearate, aluminum stearate and stearic acid; or liquid lubricants such as but not limited to simethicone, lecithin, vegetable oil, olive oil, or mineral oil.
- the lubricant is added at a percentage by weight of the chewing gum product of less than 5 percent, e.g. less than 2 percent, e.g. less than 0.5 percent.
- the chewing gum product is substantially free of a hydrophobic lubricant.
- Hydrophobic lubricants include, but are not limited to, magnesium stearate, calcium stearate and aluminum stearate.
- Radiofrequency (RF) energy is used to transform the gum-base-comprising powder portion or optional powder aggregate into a chewing gum.
- RF frequency is an electromagnetic energy within the range of from about 1 MHz to about 300 MHz.
- RF treatment generally refers to applying an electromagnetic field at frequencies from about 1 MHz to about 100 MHz.
- the RF-energy is within the range of frequencies from about 1 MHz to about 100 MHz, such as from about 5 MHz to 50 MHz, such as from about 10 MHz to about 30MHz. More specific frequencies applied include frequencies of about 24.4 MHz, about 27.12 MHz, about 13.56 MHz and about 40.68MHz.
- EM energy electromagnetic energy
- MW Micro Wave
- IR Infra Red
- UV Ultraviolet
- Preferred combinations are RF energy and IR energy, RF energy and MW energy, and RF energy, IR energy and MW energy.
- the MW energy has a frequency range from about 300 Mhz to about 300 GHz.
- the IR energy has a frequency range from about 300 GHz to about 400 THz.
- the UV energy has a frequency range from about 400 THz to about 10 PHz.
- the EM energy has a frequency such that it is non-ionizing, meaning below about 1000 THz.
- frequency ranges for RF, MW, IR and UV energies is not standardized and may vary slightly between different text books.
- the above frequency ranges are among the ranges most commonly used.
- the type of EM energy mainly disclosed in the present application is RF energy. What is disclosed on RF energy in the present application is applicable mutatis mutandis on the other types of EM energy disclosed in the present application.
- the die and the compaction punch are serving as the electrodes (e.g., one can be the ground electrode) through which RF energy is delivered to the gum-base-comprising powder portion or powder aggregate.
- the electrodes e.g., one can be the ground electrode
- the punches are in direct contact with the surface of the gum-base-comprising powder portion or powder aggregate when the energy is added.
- the punches are not in contact (e.g., from about 1 mm to about 1 cm from the surface of the gum-base-comprising powder portion or powder aggregate) during the addition of the energy.
- the powder aggregate and at least one of the one or more deposits are concomitantly treated with RF energy.
- the RF energy is delivered once the gum aggregate is shaped. In one embodiment, the energy is delivered continuously starting when the densification begins. In one embodiment, the RF energy is delivered after the gum aggregate has been removed from the die.
- the punch and/or the forming die can optionally have electrically insulated side walls and/or can be fully electrically insulated. In such an embodiment, the RF energy can be delivered through insulated electrodes or through electrodes which are not in direct contact with the powder aggregate or separated from the powder aggregate by an air gap.
- the die is non- conductive such that it cannot conduct RF energy, in that the energy is directly applied to the powder portion or powder aggregate. In this embodiment, only the punches are conductive.
- the die is constructed of plastic, polyethylene, high density polyethylene, polyvinylchloride, polypropylene, high density polypropylene, or Teflon®.
- the punches are non-conductive and portions of the die act as two electrodes in order to direct and deliver the RF energy to the powder portion or powder aggregate.
- the chewing gum is cooled within the die.
- the cooling can be passive cooling (e.g., at room temperature) or active cooling (e.g., coolant recirculation cooling).
- active cooling e.g., coolant recirculation cooling
- the coolant can optionally circulate through channels inside the punches or punch platen and/or the die or die platen.
- the process uses a die platen having multiple die cavities and upper and lower punch platens having multiple upper and lower punched for simultaneous forming of a plurality of chewing gums wherein the platens are actively cooled.
- RF energy is combined with a second source of energy including but not limited to conduction, infrared, induction, or convection heating.
- a second source of energy including but not limited to conduction, infrared, induction, or convection heating.
- the powder portion and/or powder aggregate provides resistance between two non-RF electrodes, and heat is generated as a result of resistance upon the addition of electricity.
- the chewing gum further comprises at least one deposit (e.g., to add crispiness, enhance taste, provide an alternative or additional source of nicotine and/or buffering agent or protect the gum during storage).
- deposits include, but are not limited to, layers, films, coatings, such as sugar coatings, film coatings, press coatings, compression coatings and melt coatings, beads, tablets, capsules, flakes, granules, pills, pastilles, hard-boiled lozenges, jelly gums and gels and/or combinations thereof, whereby optionally said deposits may be fracture sensitive and may initially comprise powder.
- the coating may be manually placed or sprayed onto the chewing gum product in rotating pans of different shapes or fluidized beds.
- Sugar coating is a multistep process and may be divided into the following steps: (i) sealing of the chewing gum product; (ii) subcoating; (iii) smoothing or glossing; (iv) coloring; (v) polishing; and (vi) optionally printing.
- Sugar coated gums have a smoother profile with less visible edges remaining from the original core.
- Sub-coating e.g., either by dusting with powder on the polyol solution or application of dry powder in the polyol solution, may be used.
- the chewing gum may also be coated by a panning technique, e.g., using a sugar coating pan, or other more sophisticated techniques capable of some degree of automation.
- the sugar in a sugar coating may be sucrose or other types of sugar, such as sugar alcohols, and/or an artificial sweetener.
- Film coating involves the deposition, usually by a spray method, of a thin film of polymer surrounding the chewing gum.
- the solution may be sprayed on to a rotated, mixed bed.
- the drying conditions permit the removal of the solvent so as to leave a thin deposition of coating material around each chewing gum.
- the one or more deposits are substantially free of RF- interacting ingredients, in which case application of the RF energy has no significant effect on the deposit itself.
- the deposit comprises ingredients that are affected by RF energy, but is devoid of gum base.
- Such deposits which initially may comprise powder, may undergo transformation by sintering and/or fusing and/or melting and/or mechanical interlocking, thereby forming a coherent body, which becomes part of the chewing gum.
- a deposit such as, but not limited to, directly compressed tablets, beads, capsules, flakes, granules, pills, pastilles, hard-boiled lozenges or jelly gums may be dispensed adjacent to a gum-base-comprising powder portion. Upon RF treatment a unitary chewing gum is obtained.
- the nicotine and the buffer are separated from each other by being kept in separate deposits. See further in the below examples. Interior Deposits
- a deposit is incorporated into the powder portion or powder aggregate before the RF energy is applied.
- Useful such deposits include, but are not limited to, beads, tablets, capsules, flakes, granules, pills, pastilles and gels and/or combinations thereof, whereby optionally said deposits may initially comprise powder.
- the nicotine is present in a gel bead, which is liquid filled or semi-solid filled.
- the gel bead(s) may be added as a part of the powder or the powder blend.
- the chewing gum allows for the incorporation of liquid or semisolid filled particles, beads, flakes or other fracture sensitive formats which would have ruptured had they been subjected to the stresses involved in traditional mixing, rolling and scoring or direct compression gum manufacturing.
- the one or more deposits are substantially free of RF- interacting ingredients, in which case application of the RF energy has no significant effect on the deposit itself.
- the deposit comprises ingredients that are affected by RF energy but is devoid of gum base.
- Such deposits which initially may comprise powder, may undergo transformation by sintering and/or fusing and/or melting and/or mechanical interlocking, thereby forming a coherent body which becomes part of the chewing gum.
- the chewing gum comprises at least one exterior deposit and at least one interior deposit.
- the present invention may encompass a number of further embodiments, such as
- said punch may comprise an electrode, which delivers said RF energy to said powder aggregate.
- said die comprises an electrode, which delivers said RF energy to said powder aggregate.
- said gum-base comprising powder is densified using an upper punch and a lower punch, and at least one of said upper punch or lower punch comprises an electrode, which delivers said RF energy to said powder aggregate.
- At least one of forming, making and adhering of one or more of said one or more deposit(s) takes place concomitantly with the processing of the gum base-comprising powder.
- At least one of forming, making and adhering of one or more of said one or more deposit(s) take(s) place separately from the processing of the gum base-comprising powder.
- At least one of said one or more deposit(s) is made using application of RF energy.
- At least one of said one or more deposit(s) is made using any of
- At least one of said one or more deposits provides a crispy and/or crunchy mouth- feel to a person chewing said chewing gum.
- One or more deposits are located at least partly at the peripheral part of the chewing gum.
- One or more deposits are located at least partly within the chewing gum.
- the gum-base comprising powder is a blend of powders with different properties.
- the present invention features a method of treating tobacco dependence and/or providing satisfaction equivalent to the satisfaction experienced from use of tobacco, such a smoking or use of smoke-less tobacco.
- a unit dose is typically accompanied by dosing directions, which instruct the patient to take an appropriate amount of the nicotine that may be a multiple of the unit dose depending on, e.g. how strong the patient's tobacco dependence is.
- the powder blend of Table 1 is prepared as follows.
- the colorant, flavor, acesulfame K, and sucralose are manually passed through a 50 mesh screen.
- the above mixture and remaining materials are added to a plastic bottle, mixed end-over end for approximately three minutes, and then discharged.
- the powder blend is then individually dispensed into a simulated tablet-like medicament die utilizing 1000 mg of the blend per die.
- the die is constructed of a non- conductive plastic and the punches act as electrodes within an RF unit.
- the powder portions are then treated with RF energy for 15 seconds to transform the powder portion into a chewing gum.
- the chewing gum is then ejected from the die.
- the powder blend of Table 2 is prepared as follows.
- the colorant, flavor, acesulfame K, and sucralose are manually passed through a 50 mesh screen.
- the above mixture and remaining materials including the nicotine bitartrate dihydrate are added to a plastic bottle, mixed end-over end for approximately three minutes, and then discharged.
- the powder blend is then individually dispensed into a simulated tablet-like medicament die utilizing 1000 mg of the blend per die.
- the die is made by a non-conductive plastic and the punches act as electrodes within an RF unit.
- the powder portions are then treated with RF energy for 15 seconds to transform the powder portion into a chewing gum.
- the chewing gum is then ejected from the die.
- the powder blend of Table 3 is prepared as follows.
- the colorant, flavor, acesulfame K, and sucralose are manually passed through a 50 mesh screen.
- the above mixture and remaining materials including the nicotine resin complex and the
- Trometamol are added to a plastic bottle, mixed end-over end for approximately three minutes, and then discharged.
- the powder blend is then individually dosed into a simulated tablet-like medicament die utilizing 1000 mg of the blend per die.
- the die is constructed of a non-conductive plastic and the punches act as electrodes within an RF unit.
- the gum shapes are then heated and activated utilizing RF energy for 15 seconds to sinter the granulation into a unified chewing gum product.
- the chewing gum product is then ejected from the die.
- the powder blend of Table 4 is prepared as follows.
- the colorant, flavor, acesulfame K, and sucralose are manually passed through a 50 mesh screen.
- the above mixture and remaining materials including the nicotine resin complex are added to a planetary mixer type Kitchen Aid and mixed for approximately five minutes, then magnesium stearate is added and mixed for a period of additionally 2.5 min and the material is then discharged.
- the powder blend is then individually dosed into a simulated tablet-like medicament die utilizing 1000 mg of the blend per die.
- the die is constructed of a non-conductive plastic and the punches act as electrodes within an RF unit.
- the gum shapes are then heated by RF energy for 15 seconds to sinter the granulation into a unified chewing gum product.
- the chewing gum product is then ejected from the die.
- the powder blend of Table 6a is prepared as follows ("Gum Powder Blend”).
- the colorant, flavor, acesulfame K, and sucralose are manually passed through a 50 mesh screen.
- the above mixture and remaining materials including the nicotine resin complex and the sodium bicarbonate and sodium carbonate are added to a plastic bottle, end-over-end for approximately three minutes, and then discharged.
- the powder blend of Table 6b (“Isomalt Powder Blend”) is prepared by adding the Galen IQ, the cinnamon, the sucralose and the sodium stearyl fumarate into a plastic bottle and mixing end-over-end for approximately 3 minutes and then discharged.
- the powder blend of Table 7 is prepared as follows. Isomalt, Sodium carbonate anhydrous, Sodium hydrogen carbonate, Acesulfame Potassium, Sucralose, flavour in powder form and Magnesium oxide are sieved and loaded to a powder mixer together with the Nicotine Resinate. The raw materials are then mixed together to form a powder premix.
- the chewing gum base is milled together with amorphous silica and passed through a 1,0 mm screen.
- the milled gum base and amorphous silica are then added to the powder premix and mixed to form a homogenous distribution of the ingredients, finally the magnesium stearate is added and mixed for a few minutes.
- the powder blend is then individually dosed into a simulated tablet-like medicament die utilizing 1000 mg of the blend per die.
- the die is constructed of a non-conductive plastic and the punches act as electrodes within an RF unit.
- the gum shapes are then heated utilizing RF energy for 30 seconds to sinter the granulation into a unified chewing gum product.
- the chewing gum product is then ejected from the die. Also other percentages of gum base content are possible, e g from about 10 % to about 80 %.
- the powder blend of Table 8 is prepared as follows.
- the Chewing Gum Base, Sodium carbonate anhydrous, Sodium hydrogen carbonate, Acesulfame Potassium, Sucralose and Magnesium oxide are sieved and loaded to a powder mixer together with the encapsulated flavours and Nicotine Resinate.
- the raw materials are then mixed together to form a homogenous distribution of the ingredients, finally the magnesium stearate is added and mixed for a few minutes.
- Active ingredient (mg) (mg) (mg) (mg) (mg) (mg) (mg) (mg) (mg) (mg) (mg)
- Nicotine resin 0 2,5 5 10 15 20 complex 20%
- Chewing gum base 905 902,5 900 895 890 885 for compression (HiG
- Encapsulated flavour 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 Encapsulated flavour 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20
- the powder blend is then individually dosed into a simulated tablet-like medicament die utilizing 1000 mg of the blend per die.
- the die is constructed of a non- conductive plastic and the punches act as electrodes within an RF unit.
- the gum shapes are then treated utilizing RF energy for 15 seconds to sinter the granulation into a unified chewing gum product.
- the chewing gum product is then ejected from the die.
- the amount of buffers may be adjusted to achieve desired nicotine absorption kinetics.
- the powder blend of Table 9a is prepared as follows ("Gum Powder Blend”).
- the colorant, flavor, acesulfame K, and sucralose are manually passed through a 50 mesh screen.
- the above mixture and remaining materials including the nicotine resin complex and the sodium bicarbonate and sodium carbonate are added to a plastic bottle, mixed end-over-end for approximately three minutes, and then discharged.
- Acesulfame K 0.20 2.00 0.20
- the poly dextrose powder blend of Table 9b is prepared by adding the polydextrose, the cinnamon, the sucralose and the sodium stearyl fumarate into a plastic bottle and mixing end-over-end for approximately 3 minutes and then discharged.
- Polydextrose may be exchanged for hydrogenated starch hydrosylate or cornstarch.
- 300 mg of the Polydextrose is added to the die and densified at approximately 5 kP. Then, 1000 mg of the Gum Powder Blend is added to the polydextrose layer within the die, and treated utilizing RF energy for 15 seconds to sinter the isomalt layer and the gum blend into a unified bilayer dosage form. The bilayer chewing gum is then ejected from the die.
- the powder blend of Table 10a is prepared as follows ("Gum Powder Blend”).
- the colorant, flavor, acesulfame K, and sucralose are manually passed through a 50 mesh screen.
- the above mixture and remaining materials including the nicotine resin complex and the sodium bicarbonate and sodium carbonate are added to a plastic bottle, mixed end-over-end for approximately three minutes, and then discharged.
- the polydextrose powder blend of Table 10b is prepared by adding the polydextrose, the mint flavor, the sucralose and the sodium stearyl fumarate into a plastic bottle and mixing end-over-end for approximately 3 minutes and then discharged.
- Polydextrose may be exchanged for Hydrogenated starch hydrosylate or cornstarch.
- 300 mg of the Polydextrose is added to the die and densified at approximately 5 kP. Then, 1000 mg of the Gum Powder Blend is added to the polydextrose layer within the die, and treated utilizing RF-energy for 15 seconds to sinter the poly dextrose layer and the gum blend into a unified bilayer dosage form. The bilayer chewing gum product is then ejected from the die.
- the polyol layer containing isomalt also contains 1 mg nicotine resinate and the amount of isomalt is reduced with 5 mg and is compressed using 30 kN (15 mm round concave punch) in a separate compression step whereafter the chewing gum powder blend is added, a shape forming, but low, compaction pressure is added and RF-energy is applied for 15 seconds.
- the powder blend is then individually dosed into a simulated tablet-like medicament die utilizing 1000 mg of the blend per die.
- the die is constructed of a non- conductive plastic and the punches act as electrodes within an RF unit.
- the gum shapes are then treated utilizing RF energy for 15 seconds to sinter the granulation into a unified chewing gum product.
- the chewing gum product is then ejected from the die.
- Acesulfame K 0.20 2.00 0.20
- gum base comprises gum base, isomalt, sorbitol and an anticaking agent.
- the powder blend of Table 13 is prepared as follows.
- the flavor, acesulfame K, and sucralose are manually passed through a 50 mesh screen.
- the above mixture and remaining materials including the nicotine resin complex are added to a Turbula mixer, mixed end-over end for approximately eight minutes, and then discharged.
- the powder blend is then individually dosed into a simulated tablet-like medicament die utilizing 1000 mg of the blend per die.
- the die is constructed of a non- conductive plastic and the punches act as electrodes within an RF unit.
- the gum shapes are then treated with RF energy for 15 seconds to sinter the powder into a unified chewing gum product.
- the chewing gum product is then ejected from the die.
- Three separate powder blend layers where one layer is a pre-compacted layer comprising polyol and the other two layers comprise gum base, are sintered together to form a coherent chewing gum product. This procedure allows for the separation of ingredients with compatibility issues.
- the three powder blends of Table 14 are prepared as follows. Powder blends 1, 2 and 3 are added to separate plastic bottles and mixed end- over end for approximately three minutes. Blend 1 , comprising polyol, is then compressed using 30 kN (15 mm round punch) in a separate step whereafter the two gum base-comprising powder blends are consecutively added, forming a three-layered matrix utilizing a total amount of 1300 mg material per die. Finally, a shape forming but low compaction pressure is added and RF-energy is applied for 15 seconds to sinter the blends into a unified chewing gum product. The chewing gum product is then ejected from the die.
- Nicotine Resin Complex (20% 1.000 10.00* 0.77 Nicotine)
- Blend 3 Flavor-comprising gum layer
- Acesulfame K 0.200 2.00 0.15
- Two separate powder blend layers where one layer is a pre-compacted layer comprising polyol and the other layer comprise gum base, are sintered together to form a unified chewing gum product.
- the two powder blends of Table 15 are prepared as follows. Powder blend 1 is added to a plastic bottle and mixed end-over end for approximately three minutes. Blend 1, comprising polyol, is then compressed using 30 kN (15 mm round punch) in a separate step.
- the powder blend 2 is prepared as follows. Isomalt, Sodium carbonate anhydrous, Sodium hydrogen carbonate, Acesulfame Potassium, Sucralose , flavour in powder form and Magnesium oxide are sieved and loaded to a powder mixer together with the
- Nicotine Resinate The raw materials are then mixed together to form a powder blend.
- the chewing gum base is milled together with amorphous silica and passed through a 1,0 mm screen.
- the milled gum base and amorphous silica are then added to the powder premix and mixed to form a homogenous distribution of the ingredients, finally the magnesium stearate is added and mixed for a few minutes.
- the compressed tablets created from blend 1 are placed into simulated tablet-like medicament die and the blend 2, gum base-comprising powder blend is consecutively added, forming a two-layered matrix utilizing a total amount of 1300 mg material per die. Finally, a shape forming but low compaction pressure is added and RF-energy is applied for 15 seconds to sinter the blend and pre-compacted layer into a unified chewing gum product. The chewing gum product is then ejected from the die. Also other percentages of gum base content are possible, e g from about 10 % to about 80 %. The amount of buffers may be adjusted to achieve desired nicotine absorption kinetics.
- This preparation utilizes the increased excretion of saliva at mastication of chewing gum to trigger a carbon dioxide releasing reaction of effervescent agents in one of the layers. A fizzy sensation in the mouth is thus created when using the chewing gum.
- Two separate powder blend layers where one layer is a pre-compacted layer comprising effervescent agents and the other layer comprise gum base, are sintered together to form a coherent chewing gum product.
- the two powder blends of Table 16 are prepared as follows. Powder blends 1 and 2 are added to separate plastic bottles and mixed end-over end for approximately three minutes.
- Blend 1 comprising effervescent agents, is then compressed using 30 kN (15 mm round punch) in a separate step where after the gum base-comprising powder blend is added, forming a bi-layer matrix utilizing a total amount of 1300 mg material per die. Finally, a shape forming but low compaction pressure is added and RF-energy is applied for 45 seconds to sinter the blends into a unified chewing gum product. The chewing gum product is then ejected from the die.
- Nicotine Resin Complex (20% 2.000 20.00* 1.54 Nicotine)
- Acesulfame K 0.200 2.00 0.15
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Confectionery (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24531509P | 2009-09-24 | 2009-09-24 | |
US25558209P | 2009-10-28 | 2009-10-28 | |
US12/887,593 US20110070286A1 (en) | 2009-09-24 | 2010-09-22 | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
PCT/US2010/049974 WO2011038104A2 (en) | 2009-09-24 | 2010-09-23 | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2480221A2 true EP2480221A2 (en) | 2012-08-01 |
EP2480221B1 EP2480221B1 (en) | 2018-04-04 |
Family
ID=43756828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10819449.9A Active EP2480221B1 (en) | 2009-09-24 | 2010-09-23 | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110070286A1 (en) |
EP (1) | EP2480221B1 (en) |
CN (1) | CN102892413A (en) |
AR (1) | AR078439A1 (en) |
CA (1) | CA2775323C (en) |
ES (1) | ES2669037T3 (en) |
WO (1) | WO2011038104A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8871263B2 (en) | 2009-09-24 | 2014-10-28 | Mcneil-Ppc, Inc. | Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
US9907748B2 (en) * | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US10881132B2 (en) * | 2011-12-14 | 2021-01-05 | R.J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
SMP201200046B1 (en) * | 2012-10-24 | 2015-07-09 | Caffemotive Srl | A method for the production of a tablet of a ground product in powder for the extraction of beverages as well as a tablet obtainable with this method |
CN114223927A (en) | 2013-05-06 | 2022-03-25 | 尤尔实验室有限公司 | Nicotine salt formulations for aerosol devices and methods thereof |
IL308151B2 (en) * | 2013-12-05 | 2024-12-01 | Juul Labs Inc | Liquid nicotine formulations for aerosol devices and methods |
KR20160107254A (en) | 2014-01-10 | 2016-09-13 | 존슨 앤드 존슨 컨수머 인코포레이티드 | Process for making tablet using radiofrequency and lossy coated particles |
US9744128B2 (en) * | 2014-06-05 | 2017-08-29 | Mastix LLC | Method for manufacturing medicated chewing gum without cooling |
CN105455182A (en) * | 2014-09-04 | 2016-04-06 | 研能科技股份有限公司 | Method for making three-dimensionally formed meat substitutes |
EP3445344B1 (en) | 2016-04-21 | 2020-08-19 | Fertin Pharma A/S | Nicotine delivery product, related uses and oral dosage forms, and methods of production |
US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
EP3520632A4 (en) * | 2016-11-10 | 2020-06-17 | Japan Tobacco Inc. | Spherical powder aggregate, and production method therefor |
AU2017363357B2 (en) * | 2016-11-28 | 2023-10-05 | Kenvue Brands Llc | Process for making a coated dosage form |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
CN108323792B (en) * | 2018-01-03 | 2021-05-07 | 云南中烟工业有限责任公司 | A kind of nicotine-gentisate complex crystal, its preparation method and tobacco product comprising the same |
CN112979614B (en) * | 2021-02-09 | 2022-09-13 | 西北大学 | Nicotine-phthalic acid composite crystal, preparation method and application thereof |
CN113197327B (en) * | 2021-05-13 | 2022-11-04 | 云南中烟工业有限责任公司 | Gels based on long-chain alkyl dibasic fatty acid nicotine salt gelling agents |
CN117158634A (en) * | 2023-09-27 | 2023-12-05 | 东莞市吉纯生物技术有限公司 | Cigarette product, nicotine salt and preparation method thereof, smoking material and preparation method thereof |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US606078A (en) * | 1898-06-21 | Christian pattberg | ||
US2887437A (en) * | 1956-08-22 | 1959-05-19 | Pfizer & Co C | Palatable vitamin tablet containing an amino acid |
US3071470A (en) * | 1959-12-24 | 1963-01-01 | Bishop Lee Porter | Method for preparing soluble coffee wafers |
US3337116A (en) * | 1965-06-09 | 1967-08-22 | Container Corp | Snap lock arrangement |
NL6808619A (en) * | 1968-06-19 | 1969-12-23 | ||
DE2246013A1 (en) * | 1972-09-20 | 1974-03-28 | Boehringer Mannheim Gmbh | PROCESS FOR THE MANUFACTURING OF POROUS TABLETS |
US4158411A (en) * | 1976-05-10 | 1979-06-19 | Hall Douglas C | Dispensing package |
US4268465A (en) * | 1978-01-27 | 1981-05-19 | Massachusetts Institute Of Technology | Method of accelerating the cooling of polymeric articles |
US4268238A (en) * | 1978-03-13 | 1981-05-19 | Clint, Inc. | Flow molding |
US4260596A (en) * | 1979-08-13 | 1981-04-07 | Bristol-Myers Company | Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same |
US4327076A (en) * | 1980-11-17 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
US4398634A (en) * | 1981-11-12 | 1983-08-16 | Wrapade Machine Company, Inc. | Child-proof package system |
US4994260A (en) * | 1982-05-28 | 1991-02-19 | Astra Lakemedel Aktiebolag | Pharmaceutical mixture |
GB2137470B (en) * | 1983-04-08 | 1986-11-26 | Meiji Seika Kaisha | Fleecy confectionery producing machine |
US4508740A (en) * | 1983-07-11 | 1985-04-02 | General Foods Corporation | Tabletted beverage composition containing dipeptide sweetener and process therefore |
US4609543A (en) * | 1983-11-14 | 1986-09-02 | Nabisco Brands, Inc. | Soft homogeneous antacid tablet |
US4758439A (en) * | 1984-06-11 | 1988-07-19 | Godfrey Science & Design, Inc. | Flavor of zinc supplements for oral use |
US4590075A (en) * | 1984-08-27 | 1986-05-20 | Warner-Lambert Company | Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation |
US4684534A (en) * | 1985-02-19 | 1987-08-04 | Dynagram Corporation Of America | Quick-liquifying, chewable tablet |
US4642903A (en) * | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
US4832956A (en) * | 1985-09-25 | 1989-05-23 | Gerhard Gergely | Disintegrating tablet and process for its preparation |
IE58401B1 (en) * | 1986-06-20 | 1993-09-08 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
US4762719A (en) * | 1986-08-07 | 1988-08-09 | Mark Forester | Powder filled cough product |
US4828845A (en) * | 1986-12-16 | 1989-05-09 | Warner-Lambert Company | Xylitol coated comestible and method of preparation |
US4824681A (en) * | 1986-12-19 | 1989-04-25 | Warner-Lambert Company | Encapsulated sweetener composition for use with chewing gum and edible products |
US4851226A (en) * | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
US4857331A (en) * | 1988-03-31 | 1989-08-15 | Warner-Lambert Company | Sugarless pectin delivery system |
US5112616A (en) * | 1988-11-30 | 1992-05-12 | Schering Corporation | Fast dissolving buccal tablet |
US4906478A (en) * | 1988-12-12 | 1990-03-06 | Valentine Enterprises, Inc. | Simethicone/calcium silicate composition |
US4984240A (en) * | 1988-12-22 | 1991-01-08 | Codex Corporation | Distributed switching architecture for communication module redundancy |
US5082436A (en) * | 1989-07-14 | 1992-01-21 | General Electric Company | Apparatus for deforming thermoplastic material using RF heating |
NZ234587A (en) * | 1989-08-04 | 1991-11-26 | Mcneil Ppc Inc | A chewable pharmaceutical tablet of compressed coated granules |
US5139407A (en) * | 1989-09-01 | 1992-08-18 | General Electric Company | Apparatus for reducing thermoplastic material compression mold cycle time |
EP0416791A2 (en) * | 1989-09-08 | 1991-03-13 | General Motors Corporation | Method and apparatus for compression moulding with dielectric heating |
US5178878A (en) * | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5223264A (en) * | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
US5013557A (en) * | 1989-10-03 | 1991-05-07 | Warner-Lambert Company | Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same |
US5275822A (en) * | 1989-10-19 | 1994-01-04 | Valentine Enterprises, Inc. | Defoaming composition |
US5558880A (en) * | 1989-12-22 | 1996-09-24 | Janssen Pharmaceutica Inc. | Pharmaceutical and other dosage forms |
US5215756A (en) * | 1989-12-22 | 1993-06-01 | Gole Dilip J | Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
US5134260A (en) * | 1990-06-27 | 1992-07-28 | Carnegie-Mellon University | Method and apparatus for inductively heating powders or powder compacts for consolidation |
US5046618A (en) * | 1990-11-19 | 1991-09-10 | R. P. Scherer Corporation | Child-resistant blister pack |
US5126151A (en) * | 1991-01-24 | 1992-06-30 | Warner-Lambert Company | Encapsulation matrix |
US5286497A (en) * | 1991-05-20 | 1994-02-15 | Carderm Capital L.P. | Diltiazem formulation |
AU653423B2 (en) * | 1991-05-28 | 1994-09-29 | Mcneil-Ppc, Inc. | Chewable drug-delivery composition |
CA2068402C (en) * | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Taste mask coatings for preparation of chewable pharmaceutical tablets |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
US5304055A (en) * | 1991-11-27 | 1994-04-19 | Nabisco, Inc. | Apparatus and methods for the production of three-dimensional food products |
EP0553777B1 (en) * | 1992-01-29 | 2002-04-24 | Takeda Chemical Industries, Ltd. | Fast dissolving tablet and its production |
CA2095776C (en) * | 1992-05-12 | 2007-07-10 | Richard C. Fuisz | Rapidly dispersable compositions containing polydextrose |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
WO1995001782A2 (en) * | 1993-07-09 | 1995-01-19 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
ZA945944B (en) * | 1993-08-13 | 1996-02-08 | Eurand America Inc | Procedure for encapsulating nsaids |
US5622719A (en) * | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
NL9400040A (en) * | 1994-01-10 | 1995-08-01 | Suiker Unie | Process for preparing polysaccharide derivatives. |
US5635210A (en) * | 1994-02-03 | 1997-06-03 | The Board Of Regents Of The University Of Oklahoma | Method of making a rapidly dissolving tablet |
US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
BR9709829A (en) * | 1996-06-17 | 1999-11-16 | Janssen Pharmaceutica Nv | Biconvex dosage forms of rapid disintegration |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
US5939091A (en) * | 1997-05-20 | 1999-08-17 | Warner Lambert Company | Method for making fast-melt tablets |
ATE288742T1 (en) * | 1997-07-10 | 2005-02-15 | Gergely Dr & Co | SOLUBLE, GUM-CONTAINED, CHEWABLE TABLET |
US6103260A (en) * | 1997-07-17 | 2000-08-15 | Mcneil-Ppc, Inc. | Simethicone/anhydrous calcium phosphate compositions |
US5886081A (en) * | 1997-08-05 | 1999-03-23 | Rockwell Science Center, Inc. | Efficient dielectrically heatable compound and method |
HUP0101282A3 (en) * | 1998-03-16 | 2005-03-29 | Yamanouchi Pharma Tech Inc | Tablets quickly disintegrating in the oral cavity and process for producing the same |
ATE303798T1 (en) * | 1998-07-17 | 2005-09-15 | Janssen Pharmaceutica Nv | GRANULES WITH A FUNGICIDE AND A POLYMER COVERED CORE |
US6358060B2 (en) * | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6060078A (en) * | 1998-09-28 | 2000-05-09 | Sae Han Pharm Co., Ltd. | Chewable tablet and process for preparation thereof |
TR200101216T2 (en) * | 1998-11-02 | 2001-08-21 | Marla J. Church | Multiple particle modified release composition |
US6270805B1 (en) * | 1998-11-06 | 2001-08-07 | Andrx Pharmaceuticals, Inc. | Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20030161879A1 (en) * | 1999-06-29 | 2003-08-28 | Shinji Ohmori | Tablets quickly disintegrating in mouth |
US6284270B1 (en) * | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
US6649888B2 (en) * | 1999-09-23 | 2003-11-18 | Codaco, Inc. | Radio frequency (RF) heating system |
US6277409B1 (en) * | 2000-02-11 | 2001-08-21 | Mcneil-Ppc, Inc. | Protective coating for tablet |
US6258381B1 (en) * | 2000-02-11 | 2001-07-10 | Mcneil-Ppc, Inc. | Tablet and process for making the same |
US6647061B1 (en) * | 2000-06-09 | 2003-11-11 | General Instrument Corporation | Video size conversion and transcoding from MPEG-2 to MPEG-4 |
DE10029201A1 (en) * | 2000-06-19 | 2001-12-20 | Basf Ag | Retarded release oral dosage form, obtained by granulating mixture containing active agent and polyvinyl acetate-polyvinyl pyrrolidone mixture below the melting temperature |
WO2002076229A1 (en) * | 2001-03-23 | 2002-10-03 | Gumlink A/S | One-step process for preparing chewing gum |
US6767200B2 (en) * | 2001-09-28 | 2004-07-27 | Mcneil-Ppc, Inc. | Systems, methods and apparatuses for manufacturing dosage forms |
US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
CA2446759A1 (en) * | 2001-09-28 | 2003-04-03 | Mcneil-Ppc, Inc. | Modified release dosage forms |
US6753009B2 (en) * | 2002-03-13 | 2004-06-22 | Mcneil-Ppc, Inc. | Soft tablet containing high molecular weight polyethylene oxide |
GB0208587D0 (en) * | 2002-04-13 | 2002-05-22 | Stanelco Fibre Optics Ltd | Capsules |
WO2003101431A1 (en) * | 2002-06-04 | 2003-12-11 | J.B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical composition for controlled drug delivery system |
US7807197B2 (en) * | 2002-09-28 | 2010-10-05 | Mcneil-Ppc, Inc. | Composite dosage forms having an inlaid portion |
JP2006509771A (en) * | 2002-11-25 | 2006-03-23 | パーデュー・リサーチ・ファウンデイション | Fast-dissolving tablets based on mannose |
EP1599186B1 (en) * | 2003-02-24 | 2013-04-10 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US20070196477A1 (en) * | 2004-04-30 | 2007-08-23 | Withiam Michael C | Rapidly dissolving tablets comprising low surface area calcium phosphates |
NZ552841A (en) * | 2004-08-04 | 2009-07-31 | Alza Corp | Controlled release dosage form comprising two layers, wherein the delay layer is substanially free of non-microencapsulated drug |
US20070184111A1 (en) * | 2006-02-03 | 2007-08-09 | Pharmavite Llc | Hybrid tablet |
US20070194093A1 (en) * | 2006-02-22 | 2007-08-23 | Graphic Packaging International, Inc. | Flat blank carton |
JP2009535397A (en) * | 2006-05-02 | 2009-10-01 | パナセア バイオテック リミテッド | Transmucosal composition |
TWI547282B (en) * | 2007-07-02 | 2016-09-01 | 愛戴爾製藥股份有限公司 | Orally disintegrating tablet compositions of lamotrigine |
US20090060983A1 (en) * | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
BRPI0816890A2 (en) * | 2007-09-18 | 2015-03-24 | Niconovum Ab | Chewing Gum Composition, Use of a Nicotine-Cellulose Combination, Maltitol and a Gum Base, and Method for Preparing a Chewing Gum Composition |
EP2217213B1 (en) * | 2007-10-31 | 2017-05-24 | Johnson & Johnson Consumer Inc. | Orally disintegrative dosage form |
DK2229158T3 (en) * | 2007-12-20 | 2016-12-12 | Fertin Pharma As | Compressed chewing gum tablet |
US8871263B2 (en) * | 2009-09-24 | 2014-10-28 | Mcneil-Ppc, Inc. | Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
-
2010
- 2010-09-22 US US12/887,593 patent/US20110070286A1/en not_active Abandoned
- 2010-09-23 CA CA2775323A patent/CA2775323C/en not_active Expired - Fee Related
- 2010-09-23 EP EP10819449.9A patent/EP2480221B1/en active Active
- 2010-09-23 AR ARP100103470A patent/AR078439A1/en unknown
- 2010-09-23 CN CN2010800539163A patent/CN102892413A/en active Pending
- 2010-09-23 WO PCT/US2010/049974 patent/WO2011038104A2/en active Application Filing
- 2010-09-23 ES ES10819449.9T patent/ES2669037T3/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2775323C (en) | 2017-10-24 |
CN102892413A (en) | 2013-01-23 |
EP2480221B1 (en) | 2018-04-04 |
CA2775323A1 (en) | 2011-03-31 |
AR078439A1 (en) | 2011-11-09 |
US20110070286A1 (en) | 2011-03-24 |
WO2011038104A2 (en) | 2011-03-31 |
ES2669037T3 (en) | 2018-05-23 |
WO2011038104A3 (en) | 2013-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2775323C (en) | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process | |
CN102762197B (en) | Radio frequency is utilized to manufacture chewing gum product | |
CN1997350B (en) | Tobacco alkaloid releasing chewing gum | |
KR101168348B1 (en) | Compressed chewing gum tablet | |
DE60315724T2 (en) | PRESSED CHOPPING TABLET | |
EP2361081B1 (en) | Multi portion intra-oral dosage form and use thereof | |
RU2490010C2 (en) | Multicomponent oral dosage form with organoleptic properties | |
EP1404306B1 (en) | A coated nicotine-containing chewing gum, manufacture and use thereof | |
JP7214755B2 (en) | Tableted chewing gum suitable for pharmaceutical active ingredients | |
CN112118833B (en) | Disintegrating oral tablets suitable for active pharmaceutical ingredients | |
CN101035437B (en) | Confectionery product | |
CN100459873C (en) | Compressed chewing gum tablet Ⅱ | |
CN104271339B (en) | The method for manufacturing solid dosage forms | |
EP3463287A1 (en) | Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin | |
JPS60164438A (en) | Tablet shaped chewing gum composition and its production | |
MXPA04012407A (en) | Compressed chewing gum. | |
CN112153964A (en) | Oral tablet suitable for active pharmaceutical ingredients comprising non-directly compressible sugar alcohol particles | |
CN115515563A (en) | Compression molded packaging for oral delivery of active ingredients | |
HK1180608A (en) | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process | |
DK202330347A1 (en) | Coated soft chew tablets suitable for antacids | |
CN118103028A (en) | Multilayer dextrose tablets | |
HK1176862B (en) | Manufacture of chewing gum product with radiofrequency | |
HK1171965B (en) | Manufacture of lozenge product with radiofrequency | |
HK1160793B (en) | Multi portion intra-oral dosage form and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120330 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
R17D | Deferred search report published (corrected) |
Effective date: 20130627 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: JOHNSON & JOHNSON CONSUMER INC. Owner name: NICKLASSON, FREDRIK |
|
17Q | First examination report despatched |
Effective date: 20160808 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20171214 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KRIKSUNOV, LEO, B. Inventor name: LUBER, JOSEPH, R. Inventor name: HUGERTH, ANDREAS Inventor name: NICKLASSON, FREDRIK Inventor name: SOWDEN, HARRY, S. Inventor name: HENDENSTROM, JOHN Inventor name: LINDELL, KATARINA Inventor name: CHEN, JEN-CHI Inventor name: OLSSON, ROLAND Inventor name: KOLL, GREGORY, E. Inventor name: SZYMCZAK, CHRISTOPHER, E. Inventor name: BUNICK, FRANK, J. |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 984822 Country of ref document: AT Kind code of ref document: T Effective date: 20180415 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602010049738 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2669037 Country of ref document: ES Kind code of ref document: T3 Effective date: 20180523 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20180404 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: NO Ref legal event code: T2 Effective date: 20180404 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180704 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180705 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 984822 Country of ref document: AT Kind code of ref document: T Effective date: 20180404 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180806 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602010049738 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
26N | No opposition filed |
Effective date: 20190107 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20180930 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180930 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180930 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180930 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NO Payment date: 20190910 Year of fee payment: 10 Ref country code: FI Payment date: 20190909 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180923 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20191001 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20100923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180404 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180404 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180804 |
|
REG | Reference to a national code |
Ref country code: FI Ref legal event code: MAE |
|
REG | Reference to a national code |
Ref country code: NO Ref legal event code: MMEP |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200923 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20210811 Year of fee payment: 12 Ref country code: FR Payment date: 20210812 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20220118 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20220428 AND 20220504 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200924 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20220505 AND 20220512 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20220513 AND 20220518 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602010049738 Country of ref document: DE Owner name: NICKLASSON, FREDRIK, SE Free format text: FORMER OWNERS: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, N.J., US; NICKLASSON, FREDRIK, BJAERRED, SE Ref country code: DE Ref legal event code: R081 Ref document number: 602010049738 Country of ref document: DE Owner name: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, US Free format text: FORMER OWNERS: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, N.J., US; NICKLASSON, FREDRIK, BJAERRED, SE Ref country code: DE Ref legal event code: R081 Ref document number: 602010049738 Country of ref document: DE Owner name: JOHNSON & JOHNSON CONSUMER INC., WILMINGTON, US Free format text: FORMER OWNERS: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, N.J., US; NICKLASSON, FREDRIK, BJAERRED, SE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: S117 Free format text: REQUEST FILED; REQUEST FOR CORRECTION UNDER SECTION 117 FILED ON 10 FEBRUARY 2023 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: S117 Free format text: CORRECTIONS ALLOWED; REQUEST FOR CORRECTION UNDER SECTION 117 FILED ON 10 FEBRUARY 2023 WAS ALLOWED ON 16 FEBRUARY 2023 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602010049738 Country of ref document: DE Owner name: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, US Free format text: FORMER OWNERS: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, NJ, US; NICKLASSON, FREDRIK, BJAERRED, SE Ref country code: DE Ref legal event code: R081 Ref document number: 602010049738 Country of ref document: DE Owner name: JOHNSON & JOHNSON CONSUMER INC., WILMINGTON, US Free format text: FORMER OWNERS: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, NJ, US; NICKLASSON, FREDRIK, BJAERRED, SE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20230406 AND 20230412 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20230413 AND 20230419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220923 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602010049738 Country of ref document: DE Owner name: JOHNSON & JOHNSON CONSUMER INC., WILMINGTON, US Free format text: FORMER OWNER: JOHNSON & JOHNSON CONSUMER INC. (N.D.GES.D. STAATES NEVADA), SKILLMAN, NJ, US Ref country code: DE Ref legal event code: R081 Ref document number: 602010049738 Country of ref document: DE Owner name: JOHNSON & JOHNSON CONSUMER INC., WILMINGTON, US Free format text: FORMER OWNER: JOHNSON & JOHNSON CONSUMER INC., SKILLMAN, NJ, US |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240730 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240801 Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20240812 Year of fee payment: 15 |